Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2015

01-11-2015 | Clinical trial

Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors

Authors: Wendy Demark-Wahnefried, Graham A. Colditz, Cheryl L. Rock, Rebecca L. Sedjo, Jingxia Liu, Kathleen Y. Wolin, Helen Krontiras, Tim Byers, Bilgé Pakiz, Barbara A. Parker, Michael Naughton, Anthony Elias, Patricia A. Ganz, ENERGY Trial Group

Published in: Breast Cancer Research and Treatment | Issue 2/2015

Login to get access

Abstract

Obesity is a poor prognostic factor and is negatively related to quality of life (QOL) in breast cancer survivors. Exercise and Nutrition to Enhance Recovery and Good Health for You is the largest weight loss trial completed among cancer survivors. Percent losses in body weight with an intensive group-based intervention versus an attention control were 6.0 versus 1.5 % (p < 0.0001) and 3.7 versus 1.3 % (p < 0.0001) at 12 and 24 months, respectively. ENERGY also was designed to answer the research question: Does weight loss significantly improve vitality and physical function (key components of QOL)? 692 breast cancer survivors (BMI: 25–45 kg/m2) at 4 US sites were randomized to a year-long intensive intervention of 52 group sessions and telephone counseling contacts versus a non-intensive (control) of two in-person counseling sessions. Weight, self-reported QOL, and symptoms were measured semi-annually for two years. Significant decreases in physical function and increases in symptoms were observed among controls from baseline to 6 months, but not in the intervention arm, −3.45 (95 % Confidence Interval [CI] −6.10, −0.79, p = 0.0109) and 0.10 (95 %CI 0.04, 0.16, p = 0.0021), respectively. Improvements in vitality were seen in both arms but trended toward greater improvement in the intervention arm −2.72 (95 % CI −5.45, 0.01, p = 0.0508). These differences diminished over time; however, depressive symptoms increased in the intervention versus control arms and became significant at 24 months, −1.64 (95 % CI −3.13, −0.15, p = 0.0308). Increased QOL has been reported in shorter term diet and exercise trials among cancer survivors. These longer term data suggest that diet and exercise interventions improve some aspects of QOL, but these benefits may diminish over time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, Fabian CJ, Gucalp A, Hershman DL, Hudson MM et al (2014) American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 32:3568–3574CrossRefPubMed Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, Fabian CJ, Gucalp A, Hershman DL, Hudson MM et al (2014) American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 32:3568–3574CrossRefPubMed
2.
go back to reference Hopman WM, Berger C, Joseph L, Barr SI, Gao Y, Prior JC, Poliquin S, Towheed T, Anastassiades T (2007) The association between body mass index and health-related quality of life: data from CaMos, a stratified population study. Qual Life Tes 16:1595–1603CrossRef Hopman WM, Berger C, Joseph L, Barr SI, Gao Y, Prior JC, Poliquin S, Towheed T, Anastassiades T (2007) The association between body mass index and health-related quality of life: data from CaMos, a stratified population study. Qual Life Tes 16:1595–1603CrossRef
3.
go back to reference Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, Baumgartner KB, Bernstein L, Wang CY, Duggan C et al (2013) Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 140:159–176PubMedCentralCrossRefPubMed Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, Baumgartner KB, Bernstein L, Wang CY, Duggan C et al (2013) Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 140:159–176PubMedCentralCrossRefPubMed
4.
go back to reference Morey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, Miller P, Mitchell DC, Demark-Wahnefried W (2009) Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA 301:1883–1891PubMedCentralCrossRefPubMed Morey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, Miller P, Mitchell DC, Demark-Wahnefried W (2009) Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA 301:1883–1891PubMedCentralCrossRefPubMed
5.
go back to reference Demark-Wahnefried W, Winer EP, Rimer BK (1993) Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11:1418–1429PubMed Demark-Wahnefried W, Winer EP, Rimer BK (1993) Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11:1418–1429PubMed
6.
go back to reference Rock CL, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M et al (2013) Reducing breast cancer recurrence with weight loss, a vanguard trial: the exercise and nutrition to enhance recovery and good health for you (ENERGY) Trial. Contemp Clin Trials 34:282–295PubMedCentralCrossRefPubMed Rock CL, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J, Naughton M et al (2013) Reducing breast cancer recurrence with weight loss, a vanguard trial: the exercise and nutrition to enhance recovery and good health for you (ENERGY) Trial. Contemp Clin Trials 34:282–295PubMedCentralCrossRefPubMed
7.
go back to reference Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J et al (2015) Results of the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. J Clin Oncol 33:3169–3176CrossRefPubMed Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, Elias A, Krontiras H, Liu J et al (2015) Results of the exercise and nutrition to enhance recovery and good health for you (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. J Clin Oncol 33:3169–3176CrossRefPubMed
8.
go back to reference Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243–274CrossRefPubMed Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243–274CrossRefPubMed
9.
go back to reference Montoye H (1975) Physical activity and health: an epidemiologic study of an entire community. Prentice-Hall, Englewood Cliffs Montoye H (1975) Physical activity and health: an epidemiologic study of an entire community. Prentice-Hall, Englewood Cliffs
10.
go back to reference Milne HM, Wallman KE, Gordon S, Courneya KS (2008) Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 108:279–288CrossRefPubMed Milne HM, Wallman KE, Gordon S, Courneya KS (2008) Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 108:279–288CrossRefPubMed
11.
go back to reference Brazier J, Usherwood T, Harper R, Thomas K (1998) Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 51:1115–1128CrossRefPubMed Brazier J, Usherwood T, Harper R, Thomas K (1998) Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 51:1115–1128CrossRefPubMed
12.
go back to reference Brazier J, Roberts J, Deverill M (2002) The evaluation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMed Brazier J, Roberts J, Deverill M (2002) The evaluation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292CrossRefPubMed
13.
go back to reference Ware J Jr, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructions. Med Care 31:247–263 Ware J Jr, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructions. Med Care 31:247–263
14.
go back to reference Ware J (2004) SF-36 Health Survey update. In: Maruish ME (ed) The use of psychological testing for treatment planning and outcomes assessment, 3rd edn. Lawrence Erlbaum Associates, Mahwah (NJ) Ware J (2004) SF-36 Health Survey update. In: Maruish ME (ed) The use of psychological testing for treatment planning and outcomes assessment, 3rd edn. Lawrence Erlbaum Associates, Mahwah (NJ)
15.
go back to reference Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP (2009) Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ (Clin Res ed) 338:a3006CrossRef Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP (2009) Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ (Clin Res ed) 338:a3006CrossRef
16.
go back to reference Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100:1530–1541PubMedCentralCrossRefPubMed Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100:1530–1541PubMedCentralCrossRefPubMed
17.
go back to reference Stanton AL, Bernaards CA, Ganz PA (2005) The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97:448–456CrossRefPubMed Stanton AL, Bernaards CA, Ganz PA (2005) The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97:448–456CrossRefPubMed
18.
go back to reference Farmer ME, Locke BZ, Moscicki EK, Dannenberg AL, Larson DB, Radloff LS (1988) Physical activity and depressive symptoms: the NHANES I epidemiologic follow-up study. Am J Epidemiol 128:1340–1351PubMed Farmer ME, Locke BZ, Moscicki EK, Dannenberg AL, Larson DB, Radloff LS (1988) Physical activity and depressive symptoms: the NHANES I epidemiologic follow-up study. Am J Epidemiol 128:1340–1351PubMed
19.
go back to reference Fine J, Colditz G, Coakley E, Mosley G, Manson J, Willett W, Kawachi I (2009) A prospective study of weight change and health-related quality of life in women. JAMA 282:2136–2142CrossRef Fine J, Colditz G, Coakley E, Mosley G, Manson J, Willett W, Kawachi I (2009) A prospective study of weight change and health-related quality of life in women. JAMA 282:2136–2142CrossRef
20.
go back to reference Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16:501–514PubMed Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16:501–514PubMed
22.
go back to reference Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W (2014) Weight loss intervention trials in women with breast cancer: a systematic review. Obesity Rev 15:749–768CrossRef Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W (2014) Weight loss intervention trials in women with breast cancer: a systematic review. Obesity Rev 15:749–768CrossRef
23.
go back to reference Goodwin PJ, Segal RJ, Vallis M, Ligibel JA, Pond GR, Robidoux A, Blackburn GL, Findlay B, Gralow JR, Mukherjee S et al (2014) Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 32:2231–2239CrossRefPubMed Goodwin PJ, Segal RJ, Vallis M, Ligibel JA, Pond GR, Robidoux A, Blackburn GL, Findlay B, Gralow JR, Mukherjee S et al (2014) Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. J Clin Oncol 32:2231–2239CrossRefPubMed
24.
go back to reference Kenzik KM, Morey MC, Cohen HJ, Sloane R, Demark-Wahnefried W (2015) Symptoms, weight loss, and physical function in a lifestyle intervention study of older cancer survivors. J Geriatr Oncol. doi:10.1016/j.jgo.2015.08.004 Kenzik KM, Morey MC, Cohen HJ, Sloane R, Demark-Wahnefried W (2015) Symptoms, weight loss, and physical function in a lifestyle intervention study of older cancer survivors. J Geriatr Oncol. doi:10.​1016/​j.​jgo.​2015.​08.​004
25.
go back to reference Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C (2012) Exercise interventions on health-related quality of life for cancer survivors. The Cochrane database of systematic reviews 8: CD007566 Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C (2012) Exercise interventions on health-related quality of life for cancer survivors. The Cochrane database of systematic reviews 8: CD007566
26.
go back to reference Befort CA, Klemp JR, Austin HL, Perri MG, Schmitz KH, Sullivan DK, Fabian CJ (2012) Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat 132:631–639PubMedCentralCrossRefPubMed Befort CA, Klemp JR, Austin HL, Perri MG, Schmitz KH, Sullivan DK, Fabian CJ (2012) Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat 132:631–639PubMedCentralCrossRefPubMed
27.
go back to reference Cachelin FM, Striegel-Moore RH, Brownell KD (1998) Beliefs about weight gain and attitudes toward relapse in a sample of women and men with obesity. Obesity Res 6:231–237CrossRef Cachelin FM, Striegel-Moore RH, Brownell KD (1998) Beliefs about weight gain and attitudes toward relapse in a sample of women and men with obesity. Obesity Res 6:231–237CrossRef
28.
go back to reference Wing RR, Papandonatos G, Fava JL, Gorin AA, Phelan S, McCaffery J, Tate DF (2008) Maintaining large weight losses: the role of behavioral and psychological factors. J Consult Clin Psychol 76:1015–1021PubMedCentralCrossRefPubMed Wing RR, Papandonatos G, Fava JL, Gorin AA, Phelan S, McCaffery J, Tate DF (2008) Maintaining large weight losses: the role of behavioral and psychological factors. J Consult Clin Psychol 76:1015–1021PubMedCentralCrossRefPubMed
29.
go back to reference Chaput JP, Tremblay A (2010) Well-being of obese individuals: therapeutic perspectives. Future Med Chem 2:1729–1733CrossRefPubMed Chaput JP, Tremblay A (2010) Well-being of obese individuals: therapeutic perspectives. Future Med Chem 2:1729–1733CrossRefPubMed
Metadata
Title
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors
Authors
Wendy Demark-Wahnefried
Graham A. Colditz
Cheryl L. Rock
Rebecca L. Sedjo
Jingxia Liu
Kathleen Y. Wolin
Helen Krontiras
Tim Byers
Bilgé Pakiz
Barbara A. Parker
Michael Naughton
Anthony Elias
Patricia A. Ganz
ENERGY Trial Group
Publication date
01-11-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3627-5

Other articles of this Issue 2/2015

Breast Cancer Research and Treatment 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine